Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C E Hack

Showing results (71-80 of 369) with videos related to

Pageof 37
Sort By:
The Journal of Thoracic and Cardiovascular Surgery|May 12, 1998
Biphasic release of secretory phospholipase A2 during and after cardiopulmonary bypassP Bruins, H te Velthuis, P G Jansen, et al.
Molecular Immunology|July 1, 1997
Effect of whole and fractionated intravenous immunoglobulin on complement in vitroT E Mollnes, I H Andreassen, K Høgåsen, et al.
Digestive Diseases and Sciences|February 1, 1992
Protective effect of antithrombin III in acute experimental pancreatitis in ratsW K Bleeker, J Agterberg, G Rigter, et al.
Transplantation Proceedings|February 1, 1993
Activation of coagulation and fibrinolysis during treatment with OKT3R J ten Berge, M H Raasveld, F N van Diepen, et al.
Intensive Care Medicine|January 1, 1993
Coagulation disorders in septic shockL G Thijs, J P de Boer, M C de Groot, et al.
AIDS Research and Human Retroviruses|March 19, 1999
The relative resistance of HIV type 1-infected chimpanzees to AIDS correlates with the maintenance of follicular architecture and the absence of infiltration by CD8+ cytotoxic T lymphocytesG Koopman, A G Haaksma, J ten Velden, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 29, 2000
C-reactive protein and cardiovascular disease: linked by complement?W K Lagrand, C A Visser, C E Hack, et al.
Pharmacological Reviews|March 4, 2000
C1-Esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedemaC Caliezi, W A Wuillemin, S Zeerleder, et al.
The Journal of Clinical Investigation|March 1, 1993
Recombinant C1 inhibitor P5/P3 variants display resistance to catalytic inactivation by stimulated neutrophilsE Eldering, C C Huijbregts, J H Nuijens, et al.
Journal of Clinical Pathology|February 28, 2002
Localisation of C reactive protein in infarcted tissue sites of multiple organs during sepsisA Baidoshvili, R Nijmeijer, W K Lagrand, et al.
Pageof 37

Showing results (71-80 of 369) with videos related to

Sort By:
Pageof 37
The Journal of Thoracic and Cardiovascular Surgery|May 12, 1998
Biphasic release of secretory phospholipase A2 during and after cardiopulmonary bypassP Bruins, H te Velthuis, P G Jansen, et al.
Molecular Immunology|July 1, 1997
Effect of whole and fractionated intravenous immunoglobulin on complement in vitroT E Mollnes, I H Andreassen, K Høgåsen, et al.
Digestive Diseases and Sciences|February 1, 1992
Protective effect of antithrombin III in acute experimental pancreatitis in ratsW K Bleeker, J Agterberg, G Rigter, et al.
Transplantation Proceedings|February 1, 1993
Activation of coagulation and fibrinolysis during treatment with OKT3R J ten Berge, M H Raasveld, F N van Diepen, et al.
Intensive Care Medicine|January 1, 1993
Coagulation disorders in septic shockL G Thijs, J P de Boer, M C de Groot, et al.
AIDS Research and Human Retroviruses|March 19, 1999
The relative resistance of HIV type 1-infected chimpanzees to AIDS correlates with the maintenance of follicular architecture and the absence of infiltration by CD8+ cytotoxic T lymphocytesG Koopman, A G Haaksma, J ten Velden, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 29, 2000
C-reactive protein and cardiovascular disease: linked by complement?W K Lagrand, C A Visser, C E Hack, et al.
Pharmacological Reviews|March 4, 2000
C1-Esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedemaC Caliezi, W A Wuillemin, S Zeerleder, et al.
The Journal of Clinical Investigation|March 1, 1993
Recombinant C1 inhibitor P5/P3 variants display resistance to catalytic inactivation by stimulated neutrophilsE Eldering, C C Huijbregts, J H Nuijens, et al.
Journal of Clinical Pathology|February 28, 2002
Localisation of C reactive protein in infarcted tissue sites of multiple organs during sepsisA Baidoshvili, R Nijmeijer, W K Lagrand, et al.
Pageof 37